1. Home
  2. UGI vs BIO Comparison

UGI vs BIO Comparison

Compare UGI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UGI Corporation

UGI

UGI Corporation

N/A

Current Price

$36.42

Market Cap

8.5B

Sector

Utilities

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$271.80

Market Cap

7.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
UGI
BIO
Founded
1940
1952
Country
United States
United States
Employees
N/A
7450
Industry
Natural Gas Distribution
Biotechnology: Laboratory Analytical Instruments
Sector
Utilities
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UGI
BIO
Price
$36.42
$271.80
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$44.00
$358.50
AVG Volume (30 Days)
1.3M
238.3K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
4.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.88
$2.74
Revenue Next Year
$2.27
$3.05
P/E Ratio
$14.04
$9.72
Revenue Growth
N/A
N/A
52 Week Low
$29.03
$211.43
52 Week High
$41.34
$343.12

Technical Indicators

Market Signals
Indicator
UGI
BIO
Relative Strength Index (RSI) 45.36 48.13
Support Level $35.51 $266.71
Resistance Level $37.00 $289.61
Average True Range (ATR) 0.83 7.91
MACD -0.02 1.02
Stochastic Oscillator 55.63 42.97

Price Performance

Historical Comparison
UGI
BIO

About UGI UGI Corporation

UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: